Merck & Company, Inc. News Headlines

Get MRK Alerts
*Delayed - data as of Oct. 21, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    MRK After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By
Notable Two Hundred Day Moving Average Cross - MRK
10/13/2014 4:01:53 PM - BNK Invest

Dow Movers: MRK, TRV
10/13/2014 1:43:41 PM - BNK Invest

A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline
10/13/2014 12:41:02 PM - Motley Fool

Gilead Sciences Inc. Gets First Hepatitis C Cocktail Drug Approved
10/10/2014 5:18:02 PM - Motley Fool

Merck Becomes #21 Most Shorted Dow Stock, Replacing Chevron
10/10/2014 9:36:58 AM - BNK Invest

iShares U.S. Healthcare ETF Experiences Big Inflow
10/9/2014 11:05:17 AM - BNK Invest

Why companies like BAE and Bayer issued debt in US markets
10/9/2014 9:00:00 AM - Market Realist

Weighting Your Dividend Growth Stocks
10/9/2014 8:13:00 AM - Seeking Alpha

Bristol Myers Squibb Getting Close To Lung Cancer Approval For Nivolumab
10/8/2014 1:52:49 PM - Trefis

Dow Movers: DD, MRK
10/8/2014 11:42:14 AM - BNK Invest

Bristol-Myers Tells Gilead Sciences, Inc. "You Win"
10/8/2014 11:05:02 AM - Motley Fool

Called Strike 3 For Bristol-Myers Squibb: What This Says For Gilead And Its Competitors In The Hep C Market
10/8/2014 10:51:00 AM - Seeking Alpha

Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
10/7/2014 8:30:16 AM - Motley Fool

HCV: The 'C' Stands For Cure
10/7/2014 1:31:00 AM - Seeking Alpha

Merck Prices EUR 2.5 Bln Debt Offering
10/6/2014 1:04:00 PM - RTT News

Comparing America's 3 Largest Drug Manufacturers
10/6/2014 11:53:00 AM - Seeking Alpha

Gilead Sciences, Inc. Got 2 Drugs Approved, and Didn't Bother to Tell Anyone
10/4/2014 12:45:02 PM - Motley Fool

Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
10/4/2014 12:14:03 PM - Motley Fool

Lung Cancer Incidence Is the Highest in These 10 States
10/4/2014 10:12:02 AM - Motley Fool

There's a Powerful Case for Better Corporate Political Disclosure
10/4/2014 8:26:02 AM - Motley Fool

How Significant Can Keytruda Be For Merck?
10/3/2014 3:57:00 PM - Seeking Alpha

Dow Movers: XOM, DIS
10/3/2014 12:35:54 PM - BNK Invest

The Question Isn't If Gilead's Hep C Combo Will Be Approved In The US By Next Friday; The Question Is The Price Of The Regimen
10/3/2014 12:12:00 PM - Seeking Alpha

Achillion: Positioned To Deliver The Last Clinical Stage Nuc To The Highest Bidder
10/2/2014 2:48:00 PM - Seeking Alpha

Ligand Earns Milestone Payment on EU Approval of Noxafil - Analyst Blog
10/2/2014 1:00:00 PM -